3 Lesser-Known Healthcare Names With Major Upside in Store

Industry Overview - The global healthcare market is projected to grow at a 6.9% CAGR, reaching over $22.3 trillion by 2033, driven by resilient demand linked to health needs and demographics rather than economic conditions [1] Company Highlights Sanuwave Health - Sanuwave Health Inc. has a market cap of just under $300 million and reported a surprise earnings beat in its second-quarter report, with a 42% year-over-year revenue increase [3][4] - The UltraMIST system, which promotes wound healing, saw sales increase by 61% year-over-year, contributing to a high gross margin of 78.3% [4] - The company's business model includes both one-time equipment purchases and recurring high-margin consumable components, supporting ongoing revenue growth [5] - Analysts have a positive outlook on Sanuwave, with a consensus price target suggesting a potential gain of approximately 59% from its current price [6] Amneal Pharmaceuticals - Amneal Pharmaceuticals Inc. focuses on generic pharmaceuticals and has a diversified portfolio, including FDA-approved products like Brekiya for migraines [7][8] - The company reported an EPS of 23 cents, exceeding analyst expectations, with a 3% year-over-year revenue increase and a 13% rise in adjusted EBITDA [8] - Amneal refinanced $2.7 billion in debt, reducing annual interest expenses by about $33 million, while maintaining a strong pipeline of drugs [9] - All five analysts rating Amneal shares have given a Buy recommendation, indicating an estimated 22% upside potential [9] Belite Bio - Belite Bio Inc. is a clinical-stage biotech firm developing treatments for unmet medical needs, including conditions like NASH and obesity [11][12] - The company has a promising clinical trial activity and ended the latest quarter with nearly $150 million in cash, indicating strong funding success [12] - Analysts are optimistic about Belite, with four out of five rating it as a Buy, suggesting a potential upside of nearly 32% [12]